| scholarly article | Q13442814 |
| P50 | author | Ralf H Adams | Q42126165 |
| Akiyoshi Uemura | Q42635567 | ||
| P2093 | author name string | Gou Young Koh | |
| Doheon Lee | |||
| Sangyong Jon | |||
| Won Do Heo | |||
| Shin-Ichi Nishikawa | |||
| Yoko Fukushima | |||
| Chan Kim | |||
| Hiroshi Kataoka | |||
| Injune Kim | |||
| Jinmyung Jung | |||
| Jin-Sung Park | |||
| Intae Park | |||
| Junyeop Lee | |||
| Hanseul Yang | |||
| Phei Er Saw | |||
| P433 | issue | 1 | |
| P921 | main subject | tumor angiogenesis | Q110495869 |
| P304 | page(s) | 102-117 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption. | |
| P478 | volume | 25 |
| Q49207442 | A novel genomic signature predicting FDG uptake in diverse metastatic tumors. |
| Q36147109 | ARHGAP18: an endogenous inhibitor of angiogenesis, limiting tip formation and stabilizing junctions |
| Q38425671 | Actin-tethered junctional complexes in angiogenesis and lymphangiogenesis in association with vascular endothelial growth factor. |
| Q39368829 | Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. |
| Q92589094 | Building Blood Vessels-One Rho GTPase at a Time |
| Q99350243 | Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity |
| Q41072129 | Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients |
| Q100394999 | Epigenetic activation of the small GTPase TCL contributes to colorectal cancer cell migration and invasion |
| Q37302839 | Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells. |
| Q46320990 | Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma. |
| Q42644178 | Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. |
| Q61800847 | Pancreatic adenocarcinomas with mature blood vessels have better overall survival |
| Q37536979 | Piezo2 protein: A novel regulator of tumor angiogenesis and hyperpermeability |
| Q37133691 | Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis. |
| Q26781332 | Rho GTPase signalling in cell migration |
| Q38230951 | Rho GTPases modulate malignant transformation of tumor cells |
| Q33909559 | Rho kinase proteins display aberrant upregulation in vascular tumors and contribute to vascular tumor growth |
| Q60947254 | Rho-Associated Coiled-Coil Kinase (ROCK) in Molecular Regulation of Angiogenesis |
| Q64244340 | Rho-Family Small GTPases: From Highly Polarized Sensory Neurons to Cancer Cells |
| Q26778344 | Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities |
| Q42581808 | RhoJ interacts with the GIT-PIX complex and regulates focal adhesion disassembly |
| Q47410671 | RhoJ promotes hypoxia induced endothelial-to-mesenchymal transition by activating WDR5 expression. |
| Q58465762 | Role of glutamine synthetase in angiogenesis beyond glutamine synthesis |
| Q92172123 | STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade |
| Q48239268 | Small GTPases orchestrate cell-cell communication during collective cell movement. |
| Q42733331 | TCL/RhoJ Plasma Membrane Localization and Nucleotide Exchange Is Coordinately Regulated by Amino Acids within the N Terminus and a Distal Loop Region |
| Q38424988 | Targeted Therapy for Breast Cancer Stem Cells by Liposomal Delivery of siRNA against Fibronectin EDB. |
| Q38696187 | The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomas |
| Q26739169 | The Role of RhoJ in Endothelial Cell Biology and Tumor Pathology |
| Q36147572 | The dynamics of Rho GTPase signaling and implications for targeting cancer and the tumor microenvironment |
| Q50897216 | Unraveling a model of TCL/RhoJ allosterism using TC10 reverse chimeras. |
Search more.